Cargando…
Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment
Direct oral anticoagulants (DOACs) are gaining popularity for patients with nonvalvular atrial fibrillation (AF) for stroke prevention. Less bleeding risk with comparable stroke prevention compared to warfarin was shown. DOACs have predictable anticoagulant effects, infrequent monitoring requirement...
Autores principales: | Jang, Soo Min, Bahjri, Khaled, Tran, Huyentran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151721/ https://www.ncbi.nlm.nih.gov/pubmed/32143504 http://dx.doi.org/10.3390/pharmacy8010030 |
Ejemplares similares
-
Potential Association of Holidays on Internationalized Normalized Ratio in Warfarin-Users at a Multidisciplinary Clinic
por: Ryu, Rachel, et al.
Publicado: (2023) -
The Usage of Concomitant Beta-Blockers with Vasopressors and Inotropes in Cardiogenic Shock
por: Ryu, Rachel, et al.
Publicado: (2022) -
Efficacy and Safety of Direct Oral Anticoagulant for Treatment of Atrial Fibrillation in Cerebral Amyloid Angiopathy
por: Narita, Koichi, et al.
Publicado: (2020) -
Efficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation
por: Cavallari, Ilaria, et al.
Publicado: (2018) -
Anticoagulation in difficult settings RELOADed: Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancer
por: Fender, Anke C., et al.
Publicado: (2019)